EA200001058A1 - Новые способы лечения нервных расстройств - Google Patents

Новые способы лечения нервных расстройств

Info

Publication number
EA200001058A1
EA200001058A1 EA200001058A EA200001058A EA200001058A1 EA 200001058 A1 EA200001058 A1 EA 200001058A1 EA 200001058 A EA200001058 A EA 200001058A EA 200001058 A EA200001058 A EA 200001058A EA 200001058 A1 EA200001058 A1 EA 200001058A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new methods
nervous disorders
treating nervous
reboxetine
ocd
Prior art date
Application number
EA200001058A
Other languages
English (en)
Other versions
EA003546B1 (ru
Inventor
Адриана Дубини
Джон Майкл Макколл
Дункан Пол Тэйлор
Филип Ф. Фон Фойгтландер
Эрик Хо Фонг Вонг
Original Assignee
Фармация Энд Апджон С.П.А.
Фармация Энд Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон С.П.А., Фармация Энд Апджон Компани filed Critical Фармация Энд Апджон С.П.А.
Publication of EA200001058A1 publication Critical patent/EA200001058A1/ru
Publication of EA003546B1 publication Critical patent/EA003546B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

В этой заявке на патент описывается лечение обсессивно-компульсивных расстройств (ОКР) и панического расстройства (ПР), включающее введение пациенту терапевтически эффективной нетоксичной дозы ребоксетина и его производных и/или фармацевтически приемлемых солей.Отчет о международном поиске был опубликован 1999.12.02.
EA200001058A 1998-04-13 1999-04-02 Новые способы лечения нервных расстройств EA003546B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
EA200001058A1 true EA200001058A1 (ru) 2001-04-23
EA003546B1 EA003546B1 (ru) 2003-06-26

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001058A EA003546B1 (ru) 1998-04-13 1999-04-02 Новые способы лечения нервных расстройств

Country Status (25)

Country Link
US (1) US6391876B1 (ru)
EP (1) EP1071418B1 (ru)
JP (1) JP2002511408A (ru)
KR (1) KR100555279B1 (ru)
CN (1) CN1197569C (ru)
AT (1) ATE277617T1 (ru)
AU (1) AU755612B2 (ru)
BR (1) BR9909476A (ru)
CA (1) CA2320722A1 (ru)
DE (1) DE69920679T2 (ru)
DK (1) DK1071418T3 (ru)
EA (1) EA003546B1 (ru)
ES (1) ES2228035T3 (ru)
HU (1) HUP0101748A3 (ru)
IL (1) IL138887A0 (ru)
IT (1) IT1305322B1 (ru)
NO (1) NO20005131D0 (ru)
NZ (1) NZ507693A (ru)
PL (1) PL194039B1 (ru)
PT (1) PT1071418E (ru)
SI (1) SI1071418T1 (ru)
SK (1) SK14482000A3 (ru)
TR (1) TR200002970T2 (ru)
WO (1) WO1999052518A2 (ru)
ZA (1) ZA200004480B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
EP1459751B1 (en) * 1999-07-01 2005-09-14 Pharmacia & Upjohn Company LLC (S,S)-reboxetine for treating migraine headaches
DE60035232T2 (de) 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
PL366119A1 (en) * 2000-11-15 2005-01-24 Eli Lilly And Company Treatment of anxiety disorders
DE60328787D1 (de) * 2002-06-17 2009-09-24 Pfizer Italia Srl Pharmazeutische salze von reboxetin
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
WO1999020279A1 (en) * 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals

Also Published As

Publication number Publication date
PL346294A1 (en) 2002-01-28
WO1999052518A3 (en) 1999-12-02
EA003546B1 (ru) 2003-06-26
TR200002970T2 (tr) 2001-01-22
CA2320722A1 (en) 1999-10-21
IL138887A0 (en) 2001-11-25
WO1999052518A2 (en) 1999-10-21
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
JP2002511408A (ja) 2002-04-16
ATE277617T1 (de) 2004-10-15
DE69920679T2 (de) 2006-03-02
SI1071418T1 (en) 2005-04-30
DK1071418T3 (da) 2005-01-03
HUP0101748A3 (en) 2001-12-28
NO20005131L (no) 2000-10-12
NO20005131D0 (no) 2000-10-12
PT1071418E (pt) 2004-12-31
CN1197569C (zh) 2005-04-20
US6391876B1 (en) 2002-05-21
KR100555279B1 (ko) 2006-03-03
ITMI980870A1 (it) 1999-10-23
EP1071418B1 (en) 2004-09-29
EP1071418A2 (en) 2001-01-31
AU755612B2 (en) 2002-12-19
NZ507693A (en) 2003-08-29
PL194039B1 (pl) 2007-04-30
DE69920679D1 (de) 2004-11-04
CN1293569A (zh) 2001-05-02
AU3635199A (en) 1999-11-01
SK14482000A3 (sk) 2001-08-06
ES2228035T3 (es) 2005-04-01
BR9909476A (pt) 2000-12-19
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24

Similar Documents

Publication Publication Date Title
EA200200111A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
NO2012015I1 (no) Dapoxetine i en hver form beskyttet av basis patent nr 330562
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
EA200001058A1 (ru) Новые способы лечения нервных расстройств
NO20005059D0 (no) Nye behandlinger for nervøse lidelser
DE69926794D1 (de) Ponazuril zur behandlung von durch coccidia neurologischen und "abortigenic" verursachten erkrankungen
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
HRP20080389A2 (en) THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS
EP1632235A3 (en) Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
PT784973E (pt) Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
EA200200559A1 (ru) Способ лечения и профилактики нейродегенеративных состояний
SE9803732D0 (sv) Nicotine treatment for obsessive compulsive disorder
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
RU2000106699A (ru) Способ лечения заболеваний методом настройки биоритмов организма

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU